Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Shared heritability and functional enrichment across six solid cancers

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Detection of PMS2 Mutations by Screening Hereditary Nonpolyposis Colon Cancer Families from Denmark and Sweden

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Estimating CDKN2A mutation carrier probability among global familial melanoma cases using GenoMELPREDICT

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Exploring the hereditary background of renal cancer in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Genomisk medicin til præimplantations-, 
præ- og postnatal diagnostik

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Germ-line mutations in the tumour suppressor genes BRCA1 and BRCA2 predispose to breast and ovarian cancer. Since 1999 we have performed mutational screening of breast and/or ovarian cancer patients in East Denmark. During this period we have identified 40 novel sequence variations in BRCA1 and BRCA2 in high risk breast and/or ovarian cancer families. The mutations were detected via pre-screening using dHPLC or high-resolution melting and direct sequencing. We identified 16 variants in BRCA1, including 9 deleterious frame-shift mutations, 2 intronic variants, 4 missense mutations, and 1 synonymous variant. The remaining 24 variants were identified in BRCA2, including 10 deleterious mutants (6 frame-shift and 4 nonsense), 2 intronic variants, 10 missense mutations and 2 synonymous variants. The frequency of the variants of unknown significance was examined in control individuals. Moreover, the presumed significance of the missense mutations was predicted in silico using the align GVGD algorithm. In conclusion, the mutation screening identified 40 novel variants in the BRCA1 and BRCA2 genes and thereby extends the knowledge of the BRCA1/BRCA2 mutation spectrum. Nineteen of the mutations were interpreted as pathogenic, 3 missense mutations were suggested to be pathogenic based on in silico analysis, 6 mutations were suggested to be benign since they were identified in patients together with a well-known disease-causing BRCA1/BRCA2 mutation, while 12 were variants of unknown significance.
Original languageEnglish
JournalFamilial Cancer
Volume10
Issue number2
Pages (from-to)207-12
Number of pages6
ISSN1389-9600
DOIs
Publication statusPublished - 2011

    Research areas

  • Breast Neoplasms, Denmark, Female, Genes, BRCA1, Genes, BRCA2, Genetic Testing, Humans, Introns, Mutation, Ovarian Neoplasms, Risk Factors

ID: 33165913